Results 61 to 70 of about 1,940,460 (362)
Background: Immune-related adverse events are associated with efficacy of immune checkpoint inhibitors (ICIs). We hypothesize that immune-mediated thrombocytopenia could be a biomarker for response to ICIs.
Hussein A Assi +4 more
doaj +1 more source
COVID-19 vaccination associated severe immune thrombocytopenia
Background Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 has emerged as a deadliest global pandemic after its identification in December 2019 in Wuhan, China resulting in more than three million deaths ...
Syed Tahir Ali Shah +3 more
semanticscholar +1 more source
Fatigue in immune thrombocytopenia [PDF]
SummaryFatigue is an important aspect of health‐related quality of life from the patient perspective and can have significant socio‐economic consequences. It is a common feature of chronic illnesses and a significant number of both adults and children with immune thrombocytopenia (ITP) suffer from fatigue.
Hill, QA, Newland, AC
openaire +3 more sources
Background: Patients with immune thrombocytopenia (ITP) are at risk of bleeding and, paradoxically, thromboembolic events (TEEs), irrespective of thrombocytopenia.
N. Cooper +8 more
semanticscholar +1 more source
The Epidemiology of Immune Thrombocytopenia
Three cases of immune thrombocytopenia (ITP) associated with human immunodeficiency virus (HIV) infection prompted a review of community‐acquired thrombocytopenia in Nova Scotia from January 1980 to December 1987. Two hundred and seven patients meeting the case definition of ITP were identified. The incidence of ITP rose from 2.0×105 in 1980 to 3.3×105
Walter F. Schlech +4 more
openaire +4 more sources
This document aims to provide practical guidance for the assessment and management of patients with thrombocytopenia, with a particular focus on immune thrombocytopenia (ITP), during the COVID‐19 pandemic.
S. Pavord +10 more
semanticscholar +1 more source
Thrombosis in immune thrombocytopenia — current status and future perspectives
Immune thrombocytopenia (ITP) is an autoimmune disorder in which a combination of defective platelet production and enhanced clearance leads to thrombocytopenia.
D. Swan +3 more
semanticscholar +1 more source
Immune Thrombocytopenia in Pregnancy [PDF]
Management of immune thrombocytopenia in pregnancy can be a complex and challenging task and may be complicated by fetal-neonatal thrombocytopenia. Although fetal intracranial hemorrhage is a rare complication of immune thrombocytopenia in pregnancy, invasive studies designed to determine the fetal platelet count before delivery are associated with ...
Evi X. Stavrou, Keith R. McCrae
openaire +3 more sources
Vaccine‐induced Immune Thrombocytopenia and Thrombosis (VITT)
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK 2Sheffield Haemophilia and Thrombosis Centre, Sheffield, UK 3Department of Haematology, Oxford University Hospitals, Oxford, UK 4Department of ...
M. Makris +4 more
semanticscholar +1 more source

